CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,860,000 | -10.7% | 248,943 | -57.2% | 0.00% | 0.0% |
| Q2 2022 | $14,398,000 | -11.1% | 581,050 | -10.0% | 0.00% | 0.0% |
| Q1 2022 | $16,191,000 | -8.9% | 645,833 | +32.4% | 0.00% | 0.0% |
| Q4 2021 | $17,765,000 | -94.3% | 487,909 | -92.0% | 0.00% | -94.5% |
| Q1 2021 | $313,141,000 | -17.8% | 6,111,277 | -0.6% | 0.06% | -21.4% |
| Q4 2020 | $380,726,000 | +3.6% | 6,148,679 | -8.3% | 0.07% | -7.9% |
| Q3 2020 | $367,343,000 | +33.1% | 6,703,334 | +39.7% | 0.08% | +24.6% |
| Q2 2020 | $276,030,000 | +66573.9% | 4,797,171 | +14519.7% | 0.06% | – |
| Q3 2018 | $414,000 | -4.2% | 32,813 | 0.0% | 0.00% | – |
| Q2 2018 | $432,000 | -83.6% | 32,813 | -82.4% | 0.00% | -100.0% |
| Q2 2013 | $2,641,000 | – | 186,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |